Recently, loss of ADAR1 function sensitized tumor cells to immunotherapy by reducing A-to-I editing of interferon-inducible RNA species and increasing dsRNA sensing by MDA5 and PKR, which led to growth inhibition and tumor inflammation [261]. The gene discussed is EIF2AK2; the disease is neoplasm.